0036 GMT - Nanosonics rises 11% to A$4.57 following its annual result, with RBC Capital Markets calling it a relief rally as shares in the medical-device maker had been weak for a while. Nanosonics reported an underlying net profit of A$20.7 million in FY 2025, above RBC's A$17.7 million forecast. It also provided maiden revenue guidance of A$215 million-A$223 million for FY 2026, implying 8-12% growth, along with other forecasts. "Management's guidance includes A$4 million of tariff impact, although there are some mitigation strategies expected to offset the majority of tariff impact at the pretax profit level," says analyst Craig Wong-Pan. Nanosonics is on course for its best close since mid-May. (david.winning@wsj.com; @dwinningWSJ)
(END) Dow Jones Newswires
August 25, 2025 20:36 ET (00:36 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.